AbbVie | ABBV - Interest Income

Stock Price
214.05
Daily Change
-11.61 -5.14%
Monthly
-2.78%
Yearly
11.63%
Q1 Forecast
216.14

AbbVie reported $72M in Interest Income for its fiscal quarter ending in September of 2025.





Interest Income Change Date
AbbVie USD 72M 10M Sep/2025
Abbott USD 77M 6M Sep/2025
ALKERMES USD 11.09M 949K Jun/2025
AstraZeneca USD 68M 16M Jun/2025
Biogen USD 32.3M 8.4M Jun/2025
BioMarin Pharmaceutical USD 18.83M 186K Jun/2025
Eisai JPY 3.11B 783M Mar/2024
Eli Lilly USD 65M 25M Sep/2025
Gilead Sciences USD 73M 21M Jun/2025
GlaxoSmithKline GBP 26M 24M Sep/2025
J&J USD 2.12 0.17 Sep/2025
Medtronic USD 114M 23M Jan/2025
Merck USD 96M 27M Sep/2025
Pacira USD 5.01M 1.89M Jun/2025
Pfizer USD 0.62 156M Sep/2025
Regeneron Pharmaceuticals USD 175.1M 300K Sep/2025
Sanofi EUR 114M 38M Sep/2025
Ultragenyx Pharmaceutical USD 5.79M 1.04M Jun/2025
United Therapeutics USD 51.3M 200K Jun/2025
Vertex Pharmaceuticals USD 122.4M 1.5M Jun/2025
Zoetis USD 19M 4M Jun/2025